How will post-lockdown restrictions impact pharmacists?
After more than 100 days in lockdown, New South Wales pharmacists reflect on the challenges of the past few months and what lies ahead.
Laudanum – a panacea for all human woes?
Laudanum’s use, and abuse, has set the tone for the use and abuse of opiates from the 17th century until the present day.
From...
What’s the impact of the upcoming insulin discontinuations?
The discontinuation of several insulin products will leave many patients struggling to adjust to new medicine strengths and devices.
Prescription rule changes to support telehealth
Australia’s Chief Health Officer has approved an amendment to PBS prescription requirements for telehealth consultations as an emergency measure during the COVID-19 response.
Wegovy approved to cut cardiovascular risk
The popular weight-loss drug Wegovy has been approved to treat cardiovascular disease in patients who are overweight or obese.
Pharmacists soon to provide shingles management
Herpes Zoster (HZ), or shingles, is a common viral infection, with one in three people developing the condition in their lifetime.
